Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report / 대한간학회지
The Korean Journal of Hepatology
;
: 83-88, 2010.
Article
Dans Anglais
| WPRIM
| ID: wpr-98606
ABSTRACT
Erythropoietic protoporphyria (EPP) is a rare disorder of heme biosynthesis caused by mutations in the gene encoding the enzyme ferrochelatase. In EPP, deficient ferrochelatase activity leads to the excessive production and biliary excretion of protoporphyrin (PP). The major clinical features of EPP are photosensitivity and hepatobiliary disease that may progress to severe liver disease, that are caused by the toxicity of PP. EPP-related liver disease has been treated medically or surgically including liver transplantation. We described a 20-year-old male with severe liver disease who was diagnosed with EPP based on clinical and laboratory findings. He was treated with cholestyramine resin. Six months after the treatment, he was doing well without any abdominal pain or photosensitivity.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Protoporphyrines
/
Bilirubine
/
Résine de cholestyramine
/
Protoporphyrie érythropoïétique
/
Oedème
/
Érythème
/
Ferrochelatase
/
Maladies du foie
Limites du sujet:
Humains
/
Mâle
langue:
Anglais
Texte intégral:
The Korean Journal of Hepatology
Année:
2010
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS